tykhr
sign in
free sign up
Esperion Therapeutics Inc
Drug Manufacturers - Specialty & Generic
Healthcare
ESPR
196 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.47
52 week high
3.83
high
2.52
52 week low
0.00
low
2.44
growth
47.62 %
previous Close
2.51
P/E ratio
market cap
278 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
62.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top